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T cell production by the thymus, thymic size, cellularity and output all decrease drastically
after puberty. Among the candidates that may mediate this decrease are the sex steroids:
hypersecretion or pharmacological administration of these hormones has long been known
to induce thymic hypocellularity, and their depletion yields thymic hypercellularity. Here we
show that a typical sex steroid, testosterone, specifically targets CD8+CD4+ double-positive
(DP) thymocytes for apoptosis via TNF- § . Anti-TNF- § monoclonal antibodies abrogated
testosterone-induced DP apoptosis, and TNF- § –/– DP thymocytes were largely resistant to
testosterone-mediated apoptosis in vivo. Testosterone accomplished this effect by up-
regulating TNF- § production and by simultaneously sensitizing DP thymocytes to TNF- § .
Thus, TNF- § is the critical mediator of sex steroid-induced apoptosis in thymocytes, and its
manipulation should provide a point of intervention to modulate T cell production in sex hor-
mone disorders.





Abbreviation: DP: CD8+CD4+ double positive DT: Depo
testosterone PNO: Peanut oil
1 Introduction
Apoptosis plays a critical role in modulating T cell pro-
duction and output from the thymus [1, 2]. This process
is induced in both useless (i.e. those that failed pre-TCR
selection or TCR-mediated intrathymic positive selec-
tion) and harmful (i.e. autoaggressive) thymocytes during
intrathymic selection. Apoptosis is also frequently
induced in thymocytes by physiological stimuli of neuro-
nal and hormonal origin and by stimulation with patho-
gens (i.e. HIV) or their products (e.e. microbial toxins).
A particularly striking example of a loss of thymic cellu-
larity and weight occurs with aging. Thymic involution
effectively begins in early childhood, but becomes dra-
matically manifest from the time of puberty [3–5]. The
molecular mechanisms underlying age-associated thy-
mic involution are still not completely understood. One of
the suspects that may induce and/or accelerate age-
associated thymic involution are the sex steroids, whose
peak of secretion correlates precisely with the decline in
thymic output. Several lines of evidence are consistent
with this view: (i) sex steroid receptors are expressed on
thymocytes [6–9]; (ii) sex steroids have long been known
to negatively modulate thymic cellularity and T cell pro-
duction/output, as documented by transient thymic
involution in physiological (e.g. pregnancy and men-
strual cycle/oestrus) and pharmacological (sex hormone
therapy) or experimental situations (reviewed) in [7];
[10–13]; and (iii) surgical or pharmacological ablation of
sex steroid secretion is known to lead to hypercellularity
of the thymus [7, 10–13]. These processes affect imma-
ture, cortical thymocytes, and have relatively little impact
upon mature T cells [7, 9].
The studies presented here were aimed at investigating
how the sex steroids affect thymic cellularity and output.
Our results clearly demonstrate that TNF- § plays an
essential role in sex steroid-mediated thymocyte apop-
tosis.
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Fig. 1. In vitro and in vivo DP thymocyte apoptotis in
response to DT stimulation. (A) DP thymocytes from B6 mice,
prepared as described in methods, were treated in vitro for
18 h with indicated doses of DT and Dex (10–7M). Apoptosis
was determined by the permeabilization/PI method [29], and
the % of cells with hypodiploid DNA, diagnostic of apoptosis,
shown as determined by marker M1. (B) B6 mice were
injected with DT in PNO at 0.5 mg/100 g body weight, or with
an equivalent volume of PNO alone. % change in DP cell
number was determined by multiplying absolute trypan blue
counts by the percentage of DP thymocytes obtained by FCM
analysis (in this experiment, absolute number of DP thymo-
cytes 72 h after treatment was 50.9 × 106 in control and
29.1 × 106 in DT-treated mice). Cell values of unmanipulated
mice were assigned the 100 % value at the beginning of the
experiment. Results are representative of four and three
experiments, for A and B, respectively.
2 Results
2.1 Testosterone stimulation induces CD4+CD8+
thymocyte apoptosis in vitro and in vivo
To investigate whether sex steroids induce thymocyte
apoptosis, we incubated enriched CD4+CD8+ double-
positive (DP) thymocytes with increasing doses of depo-
testosterone (DT) in vitro. Apoptosis was assessed in
overnight-cultured DP thymocytes by detecting hypo-
diploid nuclear content in permeabilized cells stained
with PI (Fig. 1). (This time point was elected because it
allows an accurate assesment of apoptosis with accep-
table background values. At later time points, in both
normal and knockout mice used in this study, spontane-
ous apoptosis usually increased to G 40 %, disallowing
observation of the specific effects of stimulation). Under
these conditions, DT induced DP thymocyte apoptosis in
a dose-dependent manner (Fig. 1 A). Levels of apoptosis
achieved with G 50 ? g/ml DT were comparable with
those induced by one of the strongest apoptotic stimula-
tors, dexamethasone (Fig. 1 A; see also [14]). Further-
more, in vivo treatment of mice with DT in peanut oil
(PNO) induced a pronounced drop in DP percentage and
numbers (Fig. 1 B), while treatment with PNO alone had
no effect. These results are consistent with the previous
data [9, 12] showing that both testosterone and estro-
gen, another typical sex steroid, induce profound cell
loss and apoptosis in rodent DP thymocytes.
2.2 Testosterone induces DP thymocyte
apoptosis via TNF- >
TNF- § and TNFR are both expressed in the thymus [15,
16], and our recent data indicate that this pair is involved
in thymocyte death by cAMP activators [17]. Sex ste-
roids are known to activate cAMP, prompting us to inves-
tigate the role of TNF- § in testosterone-induced apopto-
sis. We initially used a neutralizing anti-TNF- § mAb
(MP6-XT22), to treat DP thymocytes simultaneously with
DT. Fig. 2 A shows that this antibody abrogated, in a
dose-dependent manner, DT-mediated apoptosis in DP
thymocytes, while the control rat IgG1 had no effect (not
shown). By contrast, TNF- § neutralization had no effect
on DP apoptosis induced by dexamethasone; 61 % of
DP cells underwent DNA fragmentation in the presence
and 63 % in the absence of anti-TNF mAb (not shown).
The above data were confirmed in three separate experi-
ments using two different anti-TNF- § antibodies (MP6-
XT22, Fig. 2 and 2E2, not shown). These results strongly
suggest that TNF- § may be the key mediator of DT-
mediated apoptosis.
To test the relevance of these observations by a genetic
approach, we used TNF- § –/– knockout mice that have
normal thymocyte numbers and phenotype, and are oth-
erwise indistinguishable from normal counterparts [18].
DP thymocytes of these animals did not undergo apop-
tosis in response to DT stimulation in vitro, while
dexamethasone-mediated apoptosis was not impeded
(Fig. 2 B). These results definitively demonstrate an
essential role for TNF- § in the induction of DT-mediated
DP thymocyte death.
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Fig. 2. The role of TNF- § in DT-induced thymocyte apopto-
sis. (A) TNF- § neutralization abrogates DT-induced thymo-
cyte apoptosis. Assays were performed and results dis-
played as in Fig. 1 B, except that 15 ? g/ml DT was added
and cells then incubated in the absence or the presence of
increasing concentrations of the anti-TNF- § mAb MP6. Dot-
ted line indicates spontaneous apoptosis. Results are repre-
sentative of four independent experiments. (B) TNF- § –/– DP
thymocytes are resistant to DT-induced apoptosis in vitro.
Experiments were preformed and results reported exactly as
in (A).
Fig. 3. Induction of membrane and soluble TNF- § by DT. (A)
Surface staining of DP thymocytes treated with indicated
stimuli overnight and stained with the biotinylated mAb 1C6
[38] followed by streptavidin-PE. Numbers represent per-
centage of surface TNF- § + cells and were similar in three
other experiments. (B) TNF- § capture ELISA shows the 18 h
accumulation of soluble TNF- § following incubation of DP
cells in the presence of RP 7.5, DT (25 ? g/ml), LPS (2.5 ? g/
ml) or plate-bound anti-CD3 mAb (2C11, 2.5 ? g/ml). All
results are representative of a minimum of two experiments.
2.3 Mechanism of apoptosis induced by sex
steroids
The simplest explanation for the effect of DT would be
that it stimulated DP thymocytes to produce TNF- § ,
which then kills them by fratricide our suicide. To test this
hypothesis, we investigated expression of membrane
and soluble forms of TNF- § in control and stimulated DP
cells. Several reports have shown that TNF- § is pro-
cessed from the membrane-bound precursors into a sol-
uble effector form by a metalloproteinase TACE [19, 20].
However, other evidence has indicated that the mem-
brane form of TNF- § can also have marked effects in
vivo [21]. We found that both forms were induced by DT.
Cell surface staining indicated that DT was at least as
potent as anti-CD3 mAb, a typical inducer of TNF- § .
Another known TNF- § inducer, LPS, was slightly less
effective at inducing this TNF- § form (not shown). Fur-
thermore, DT induced a threefold increase in soluble
TNF- § secretion, which is again equal or superior to
other perennial TNF- § inducers (Fig. 3 B and data not
shown). Therefore, TNF- § induction is likely to contribute
to the apoptotic effect of DT.
TNF- § can induce only low levels of apoptosis in other-
wise unstimulated thymocytes [22]. Furthermore, anti-
TCR-induced DP thymocyte apoptosis is not TNF
dependent, despite a large induction of TNF- § [18, 23,
24]. It was, therefore, plausible [17] that DT might also
facilitate DP apoptosis by other means. To address this
possibility directly, recombinant murine TNF- § (rTNF- § )
was added to DP thymocytes from TNF- § –/– mice in the
presence or absence of DT. DP cells from TNF- § –/– mice
did not undergo apoptosis in the presence of either DT or
rTNF- § alone. Remarkably, TNF- § –/– DP thymocytes
underwent significant apoptosis in the presence of
rTNF- § when incubated simultaneously with DT (Fig. 4).
These data indicate that DT induces DP apoptosis by
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Fig. 4. DT sensitizes DP thymocytes to TNF- § . DP thymo-
cytes from TNF- § –/– mice were incubated either individually
or simultaneously with 10 ng/ml rTNF- § and 25 ? g/ml DT.
Dexamethasone was used as positive control. Apoptotis
was assessed as in Fig. 1 A. Results are representative of
two experiments.
Fig. 5. DP thymocytes of TNF- § –/– mice display increased
resistance to both acute and chronic testosterone stimula-
tion in vivo. (A) Control and TNF- § –/– mice were injected with
a single dose of 0.5 mg/100 g body weight DT/PNO or PNO
alone, and thymocytes examined at indicated times for the
reduction of the DP compartment as described in Fig. 1 A.
(B) Three mice/group were injected with PNO or with DT
s.c., every other day. After 14 days, thymi were harvested,
counted and analyzed for the presence of DP cells. Data are
presented as in Fig. 1 B. Absolute mean numbers of DP
thymocytes in this experiment were 53.2 × 106 and 5.1 × 106
for the normal mice, and 39.8 × 106 and 13.9 × 106 for the
TNF- § –/– mice, for the PNO- (cntrol) and DT-treated groups,
respectively. * p n 0.05 by a two-tailed Student’s t-test.
two simultaneous effects: by inducing TNF- § secretion
and by sensitizing DP thymocytes to the apoptotic effect
of TNF- § .
2.4 Resistance of TNF- > –/– DP cells to
testosterone treatment in vivo
To evaluate the physiological relevance of these findings
in vivo, we treated normal and TNF- § –/– mice with DT.
Cell numbers and subset make-up were evaluated under
two treatment regimens. In the acute injection protocol, a
single injection of DT induced progressive loss of wild-
type DP thymocytes over the course of the experiment
(72 h; Fig. 5 A). Strikingly, no such loss was evident
among thymocytes from TNF- § –/– mice (Fig. 5 A). We
also treated both types of mice chronically by injecting
them with DT every other day for 2 weeks and then eval-
uating the resistance of DP thymocytes to such treat-
ment. Upon such chronic treatment, testosterone
induced profound depletion of normal DP thymocytes,
reducing their percentage to 9.5 % of the control levels
(Fig. 5 B). By contrast, DP thymocytes from TNF- § –/–
mice exhibited significantly (p n 0.05 by a two-tailed
Student’s t-test) increased survival when challenged with
testosterone (34.7 % cells survived testosterone treat-
ment, a 3.6-fold increase over the survival of normal thy-
mocytes). Both the compensatory mechanisms that fre-
quently develop in K.O. mice and the prolonged nature of
treatment may have contributed to the fact that this
resistance was not as absolute as the resistance of the
DP cells from TNF- § –/– mice to acute DT stimulation in
vitro and in vivo (Figs. 2 and 5 A). Alternatively, it is possi-
ble that the TNF- § -mediated signaling is only one of the
several apoptotic pathways induced by sex steroids.
However, our results indicate that this is the key pathway
under physiological conditions in an unmanipulated thy-
mus. Based on these results, we conclude that TNF- §
plays a prominent, if not critical, role in the apoptosis of
DP thymocytes induced by sex steroids in vivo.
3 Discussion
Developing thymocytes readily undergo apoptosis in
response to not only TCR stimulation, but also when
stimulated via g -adrenergic/cAMP, corticosteroid and
other pathways. These pathways likely converge at a
downstream point(s) at or close to the irreversible cas-
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pase activation [1]. The precise signaling mechanism(s)
have not been dissected for any of the thymocyte apop-
tosis pathways. This failure can be blamed in part on the
redundancy of apoptosis pathways in the thymus. For
example, a general redundancy in pathways signaling
TCR-mediated negative intrathymic selection was re-
cently documented [25, 26], with FasR-FasL being one
of the dispensable backup pathways operating at high
self-antigen doses [27].
Here, we conclusively linked testosterone-induced
apoptosis to the TNF- § effector cascade. The major con-
clusion from this study is that TNF- § acts as one of the
main mediators of sex steroid-induced apoptosis in nor-
mal DP thymocytes. Treatment of normal and TNF- § –/–
mice with testosterone (Fig. 5) confirmed the relevance
of our findings in vivo. Furthermore, the doses of DT
used in our study were well within the range of DT doses
used in substitutive pharmacotherapy of sex steroid-
deficiency disorders. The fact that TNF- § –/– mice do not
have enlarged thymi and that many of their DP cells die
when stimulated with testosterone for prolonged periods
of time (albeit at a strikingly lower rate than DP cells of
normal mice) most likely reflects the action of compen-
satory mechanisms that are frequently revealed in K.O.
animals. In normal mice or in TNF- § –/– mice acutely
treated with DT, where such mechanisms are not opera-
tive, antibody-mediated or genetic TNF- § neutralization
completely abrogates DT-mediated apoptosis (Fig. 2).
An alternative explanation is that testosterone stimula-
tion of normal thymocytes also triggers other signaling
pathways that induce apoptosis in a TNF-independent
manner. Regardless of the existence and the importance
of these pathways, the main conclusion of this work
remains that TNF- § plays a very prominent, and probably
critical, role in mediating DT-induced apoptosis of DP
cells in vivo. Previously, Screpanti et al. [9] showed that
another typical sex steroid, estrogen (17- g -estradiol),
induced apoptosis among immature thymocytes [9]. In
the context of the extensive sympathic innervation of the
thymus, the presence of neurohumoral receptors and
high thymic cAMP cellular content [28–32] and the
recent findings on the effects of cAMP on thymocyte
development [17, 33, 34], these results elucidate an
important molecular mechanism that explains the nega-
tive influence of the neurohumoral axis on thymocyte
production/output. Our recent findings [17] on the mech-
anisms of cAMP-induced thymocyte apoptosis further
suggest that in inducing DP thymocyte apoptosis, sex
steroids may act primarily via cAMP, and that this signal-
ing axis promotes TNF- § susceptibility in DP thymo-
cytes, likely by degrading cellular pools of the anti-
apoptotic molecule TRAF-2. Thus, TNF- § is an important
regulator of not only peripheral [35, 36] but also thymic
homeostasis.
The most dramatic manifestations of sex steroid influ-
ence on thymic cellularity include the well-known phe-
nomena of thymocyte depletion following stimulation
with the sex steroids in pregnancy and menstrual cycle/
estrus and of thymocyte hypercellularity following exper-
imental and pharmacological castration (reviewed in [7]).
Our results clearly point toward possible routes of inter-
vention against such immunological disturbances.
4 Materials and methods
4.1 Mice
C57BL/6 (B6) mice were obtained from the NCI Breeding
Program (Frederick, MD). TNF- § –/– mice were described pre-
viously [18]. All mice were used at 6–10 weeks of age.
4.2 Thymocyte preparation, activation and apoptosis
detection
All experiments were performed in RPMI 1640 medium sup-
plemented with pyruvate, 2-ME, L-glutamine, antibiotics and
7.5 % FBS (abbreviated RP 7.5 in the text). DP thymocytes
were enriched from total thymocytes by “panning” using
anti-CD8 mAb-coated petri dishes, as described previously
[37]. DP thymocytes were treated in 24-well flat-bottom
plates with DT (Sigma Chemical Co., St. Louis, MO) at indi-
cated concentrations, or with immobilized anti-CD3 mAb
2C11 (Pharmingen, San Diego, CA) at an optimal, pre-
titrated concentration (2.5 ? g/ml coating solution) or with
10–7 M dexamethasone (Upjohn, Kalamazoo, MI), and apop-
tosis detected by propidium iodide (PI) or Annexin V stain-
ing, as described below.
Neutralizing anti-mouse TNF- § mAb was obtained from
Pharmingen (clone MP6-XT22) or from Dr. O. Stutman
(MSKCC-mAb 2E2, [38]). Following overnight incubation,
apoptosis was assessed by quantifying the percentage of
hypodiploid nuclei undergoing DNA fragmentation using PI
staining of permeabilized cells [39], or by monitoring the
inversion of phosphatidylserine to the outer leaf of the
plasma membrane by Annexin V staining in the presence of
PI (performed according to the manufacturer’s instructions;
TACS Annexin V-FITC kit, Trevigen, Gaithersburg, MD). Flow
cytometric analysis was performed using a FACScan flow
cytometer and CellQuest 3.1 software (Becton Dickinson,
Mountain View, CA), by analyzing at least 5 × 103 cells/sam-
ple, using wide scatter gates to include late apoptotic cells.
For the sake of simplicity, results of Annexin V experiments
are reported as a percentage of total Annexin+ cells, of which
7.6–18.7 % was also PI+ (i.e. late apoptotic or necrotic),
while the remaining cells were early apoptotic. Mean values
of at least three samples/group are reported ± SD, represen-
tative of at least two independent experiments.
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4.3 ELISA for the detection of secreted TNF- >
A TNF- § capture ELISA was used to detect secreted TNF- §
in cell culture supernatants from DP thymocytes incubated
in the presence or the absence of 25 ? g/ml DT or 2.5 ? g/ml
of plate-bound mAb 2C11 (18 h at 37 °C), or 2.5 ? g/ml LPS
(Sigma), respectively. Wells of polyvinyl chloride plates
(Immulon 4; Fisher Scientific, Pittsburgh, PA) coated with
10 ? g/ml of mAb anti-TNF- § (PharMingen, San Diego, CA) in
carbonate coating buffer (pH 9.6) and blocked with 2 % FCS
PBS, were incubated with 200 ? l of cell culture supernatant.
The plates were then washed and an optimal concentration
of biotinylated anti-TNF- § polyclonal antibody (PharMingen,
San Diego, CA) added and incubated for 1 h at 37 °C. Bound
TNF- § was detected using avidin-conjugated horseradish
peroxidase (Pierce, Rockford, IL), developed using the sub-
strate * -phenylediamine dihydrochloride. The developing
reaction was stopped by adding 50 ? l of 3 M H2SO4, and the
absorbance at 490 nm was analyzed by a MCC/340 Multi-
skan microplate reader (Fisher Scientific). The assay was
carried out in quadruplicates. Results are reported as mean
values (± SD).
4.4 In vivo treatment with testosterone
Mice were treated with DT (testosterone 17 g -cypionate, cat.
no. T0141, Sigma) in sterile peanut oil (PNO) or with PNO
alone, injected s.c. at 0.5 mg/100 g body weight, as
described previously [13]. At indicated times, thymus cellu-
larity and make-up of thymic subsets were analyzed by try-
pan blue exclusion counting and FCM, respectively. Results
are shown as mean values (four mice/group) of DP thymo-
cytes, expressed as percentage relative to control DP num-
bers from PNO-treated mice. These were obtained by cal-
culating the absolute number of DP cells in control-treated
and experimental group thymi (absolute number of thymo-
cytes x % DP cells among them), with control values being
taken as 100 %.
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